Establishing the Melbourne injecting drug user cohort study (MIX): Rationale, methods, and baseline and twelve-month follow-up results

Harm Reduction Journal

Volumn 10, Issue 1, 2013, Pages

  Horyniak, Danielle ^a,b   Higgs, Peter ^a,c,d   Jenkinson, Rebecca ^a,b   Degenhardt, Louisa ^e,f   Stoové, Mark ^a,b   Kerr, Thomas ^g,h   Hickman, Matthew ⁱ   Aitken, Campbell ^a   Dietze, Paul ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Australia; Cohort; Injecting drug use; Longitudinal studies

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; COHORT ANALYSIS; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SOCIAL ASPECT; TREATMENT DURATION; URBAN AREA; LONGITUDINAL STUDY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PILOT STUDY; QUESTIONNAIRE; STATISTICS; SUBSTANCE ABUSE;

ADULT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PILOT PROJECTS; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS; VICTORIA; YOUNG ADULT;

MLCS; MLOWN;

EID: 84879110875     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-10-11     Document Type: Article

References (68)

1. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372(9651):1733-1745. 10.1016/S0140-6736(08)61311-2, 18817968.
2. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011, 378(9791):571-583. 10.1016/S0140-6736(11)61097-0, 3285467, 21802134.
3. Salmon AM, Dwyer R, Jauncey M, van-Beek I, Topp L, Maher L. Injecting-related injury and disease among clients of a supervised injecting facility. Drug Alcohol Depend 2009, 101(1-2):132-136.
4. Dwyer R, Topp L, Maher L, Power R, Hellard M, Walsh N, Jauncey M, Conroy A, Lewis J, Aitken C. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend 2009, 100(1-2):9-16.
5. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction 1996, 91(3):405-411. 10.1111/j.1360-0443.1996.tb02289.x, 8867202.
6. McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction 1998, 93(5):701-711. 10.1046/j.1360-0443.1998.9357016.x, 9692269.
7. Milloy MJ, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, Wood E. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am J Drug Alcohol Abuse 2008, 34(4):499-509. 10.1080/00952990802122457, 18584579.
8. Dietze P, Stoove M, Miller P, Kinner S, Bruno R, Alati R, Burns L. The self-reported personal wellbeing of a sample of Australian injecting drug users. Addiction 2010, 105(12):2141-2148. 10.1111/j.1360-0443.2010.03090.x, 20854337.
9. Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004, 39(1):74-80. 10.1002/hep.20014, 14752825.
10. Darke S, Mills K, Teesson M, Ross J, Williamson A, Havard A. Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatry Res 2009, 166(1):7-14. 10.1016/j.psychres.2007.12.007, 19215987.
11. Cullen W, O'Brien S, O'Carroll A, O'Kelly FD, Bury G. Chronic illness and multimorbidity among problem drug users: a comparative cross sectional pilot study in primary care. BMC Fam Pract 2009, 10:25. 10.1186/1471-2296-10-25, 2678984, 19383141.
12. Pieper B, Templin TN, Birk TJ, Kirsner RS. Effects of injection-drug injury on ankle mobility and chronic venous disorders. J Nurs Scholarsh 2007, 39(4):312-318. 10.1111/j.1547-5069.2007.00186.x, 18021130.
13. Laslett AM, Dietze P, Dwyer R. The oral health of street-recruited injecting drug users: prevalence and correlates of problems. Addiction 2008, 103(11):1821-1825. 10.1111/j.1360-0443.2008.02339.x, 19032532.
14. Saeland M, Haugen M, Eriksen FL, Smehaugen A, Wandel M, Bohmer T, Oshaug A. Living as a drug addict in Oslo, Norway-a study focusing on nutrition and health. Public Health Nutr 2009, 12(5):630-636. 10.1017/S1368980008002553, 18549520.
15. Degenhardt L, Hall W, Warner-Smith M. Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect 2006, 82(Suppl 3):iii56-iii63. 2576734, 16735295.
16. Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011, 106(1):32-51. 10.1111/j.1360-0443.2010.03140.x, 21054613.
17. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. Int J Drug Policy 2005, 13:85-94.
18. Marshall BD, Fairbairn N, Li K, Wood E, Kerr T. Physical violence among a prospective cohort of injection drug users: a gender-focused approach. Drug Alcohol Depend 2008, 97(3):237-246. 10.1016/j.drugalcdep.2008.03.028, 2570226, 18487025.
19. Milloy MJ, Wood E, Small W, Tyndall M, Lai C, Montaner J, Kerr T. Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev 2008, 27(6):693-699. 10.1080/09595230801956157, 19378451.
20. Wall M, Schmidt E, Sarang A, Atun R, Renton A. Sex, drugs and economic behaviour in Russia: a study of socio-economic characteristics of high risk populations. Int J Drug Policy 2011, 22(2):133-139. 10.1016/j.drugpo.2010.10.001, 21055913.
21. Fitzgerald J. The injecting drug use needs and impact study: Report 2A - The social and economic impact of injecting drug use 1999, Melbourne: Department of Criminology, University of Melbourne, Victorian Law Enforcement Drug Fund and City of Melbourne.
22. Ruspini E. Introduction to Longitudinal Research 2002, New York: Routledge.
23. Rochon PA, Gurwitz JH, Sykora K, Mamdani M, Streiner DL, Garfinkel S, Normand SL, Anderson GM. Reader's guide to critical appraisal of cohort studies: 1 Role and design. BMJ 2005, 330(7496):895-897. 10.1136/bmj.330.7496.895, 556167, 15831878.
24. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002, 359(9302):248-252. 10.1016/S0140-6736(02)07451-2, 11812579.
25. Wood E, Lloyd-Smith E, Li K, Strathdee SA, Small W, Tyndall MW, Montaner JS, Kerr T. Frequent needle exchange use and HIV incidence in Vancouver Canada. Am J Med 2007, 120(2):172-179. 10.1016/j.amjmed.2006.02.030, 17275459.
26. Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, Rochon PA, Anderson GM. Reader's guide to critical appraisal of cohort studies: 2 Assessing potential for confounding. BMJ 2005, 330(7497):960-962. 10.1136/bmj.330.7497.960, 556348, 15845982.
27. Marmor M, Titus S, Wolfe H, Krasinski K, Maslansky R, Simberkoff M, Beatrice S, Nichols S, Des Jarlais DC. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. AIDS Res Hum Retroviruses 1994, 10(Suppl 2):S207-S213.
28. Ruan Y, Qin G, Liu S, Qian H, Zhang L, Zhou F, He Y, Chen K, Yin L, Chen X, Hao Q, Xing H, Song Y, Wang Y, Hong K, Chen J, Shao Y. HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province China. J Acquir Immune Defic Syndr 2005, 39(4):459-463. 10.1097/01.qai.0000152398.47025.0f, 16010170.
29. Wiebel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic B, Lampinen T, Murray J, O'Brien MU. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12(3):282-289. 10.1097/00042560-199607000-00008, 8673532.
30. Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson DL, Latka MH. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend 2007, 91(Suppl 1):S4-S17.
31. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. CMAJ 2001, 165(4):405-410. 81364, 11531048.
32. Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend 2009, 101(3):152-157. 10.1016/j.drugalcdep.2008.12.007, 2692897, 19181458.
33. Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol 2003, 158(7):695-704. 10.1093/aje/kwg209, 14507606.
34. Teesson M, Mills K, Ross J, Darke S, Williamson A, Havard A. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008, 103(1):80-88. 10.1111/j.1360-0443.2007.02029.x, 17995994.
35. Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, Sargent PL. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006, 101(10):1499-1508. 10.1111/j.1360-0443.2006.01543.x, 16968352.
36. Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 2008, 48(6):1746-1752. 10.1002/hep.22534, 18844233.
37. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993, 159(4):237-241.
38. Dietze P, Fitzgerald J. Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles?. Drug Alcohol Rev 2002, 21(3):295-303. 10.1080/0959523021000002778, 12270082.
39. 3218.0 Regional Population Growth, Australia 2008-2009: Population Estimates by Local Government Area, 2001-2009 http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3218.02008-09? OpenDocument.
40. National Opioid Pharmacotherapy Statistics Annual Data collection 2010 report 2011, Canberra: Australian Institute of Health and Welfare, National Opioid Pharmacotherapy Statistics Annual Data collection.
41. Bell J, Burrell T, Indig D, Gilmour S. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. Drug Alcohol Depend 2006, 81(1):55-61. 10.1016/j.drugalcdep.2005.05.010, 15993552.
42. Day C, Degenhardt L, Hall W. Changes in the initiation of heroin use after a reduction in heroin supply. Drug Alcohol Rev 2006, 25(4):307-313. 10.1080/09595230600741040, 16854655.
43. Kral AH, Malekinejad M, Vaudrey J, Martinez AN, Lorvick J, McFarland W, Raymond HF. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health 2010, 87(5):839-850. 10.1007/s11524-010-9486-9, 2937131, 20582573.
44. Heckathorn D. Respondent-Driven Sampling: A new approach to the study of hidden populations. Soc Probl 1997, 44(2):174-199.
45. Salganik MJ, Heckathorn D. Sampling and estimation in hidden populations using respondent driven sampling. Sociol Methodol 2004, 34(1):193-240.
46. Fry CL, Hall W, Ritter A, Jenkinson R. The ethics of paying drug users who participate in research: a review and practical recommendations. J Empir Res Hum Res Ethics 2006, 1(4):21-36. 10.1525/jer.2006.1.4.21, 19385835.
47. Vandenbroucke JP, von-Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007, 4(10):e297. 10.1371/journal.pmed.0040297, 2020496, 17941715.
48. Reddel S, Horyniak D, Dietze P, McElwee P. Victorian Drug Trends 2010: Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No.58 2011, Melbourne: Burnet Institute, Turning Point Alcohol and Drug Centre & National Drug and Alcohol Research Centre (University of New South Wales).
49. Horyniak D, Dietze P, McElwee P. Victorian Drug Trends 2009: Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No.40 2010, Melbourne: Burnet Institute, Turning Point Alcohol and Drug Centre & National Drug and Alcohol Research Centre, University of New South Wales.
50. Iversen J, Topp L, Maher L. Australian NSP Survey: Prevalence of HIV, HCV and injecting and sexual behaviour among Needle and Syringe Program Attendees - National Data Report 1995-2010 2011, Sydney: The Kirby Institute for Infection and Immunity in Society, University of New South Wales.
51. Degenhardt L, Day C, Dietze P, Pointer S, Conroy E, Collins L, Hall W. Effects of a sustained heroin shortage in three Australian States. Addiction 2005, 100(7):908-920. 10.1111/j.1360-0443.2005.01094.x, 15954999.
52. Day C, Degenhardt L, Gilmour S, Hall W. Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes. BMJ 2004, 329(7463):428-429. 10.1136/bmj.38201.410255.55, 514203, 15292056.
53. Fitzgerald J, Broad S, Dare A. Regulating the street heroin market in Fitzroy/Collingwood 1998, Melbourne: VicHealth and University of Melbourne.
54. Department of Immigration and Citizenship Immigration update: 2009-2010 2010, Canberra: Department of Immigration and Citizenship, Australian Government, Department of Immigration and Citizenship.
55. City of Maribyrnong Community Profile http://profile.id.com.au/Default.aspx?id=127.
56. Aitken C, Moore D, Higgs P, Kelsall J, Kerger M. The impact of a police crackdown on a street drug scene: evidence from the street. The International journal on drug policy 2002, 13(3):193-202.
57. City of Greater Dandenong Community Profile http://www.greaterdandenong.com/Documents.asp?ID=18464&Title=Social+information+-+Victorian+municipalities.
58. Frankston City Community Profile http://profile.id.com.au/Default.aspx?id=111.
59. Livingston M. The social gradient of alcohol availability in Victoria, Australia. Aust N Z J Public Health 2012, 36(1):41-47. 10.1111/j.1753-6405.2011.00776.x, 22313705.
60. Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne Australia. J Infect 2009, 58(5):375-382.
61. Horyniak D, Higgs P, Lewis J, Winter R, Dietze P, Aitken C. An evaluation of a heroin overdose prevention and education campaign. Drug Alcohol Rev 2010, 29(1):5-11.
62. Jenkinson R, Quinn B. Victorian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS). NDARC Technical Report No. 274 2007, Melbourne: Turning Point Alcohol and Drug Centre & National Drug and Alcohol Research Centre, University of New South Wales.
63. Quinn B. Victorian Drug Trends 2007: Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No. 4 2008, Melbourne: Turning Point Alcohol and Drug Centre & National Drug and Alcohol Research Centre, University of New South Wales.
64. Fry C, Miller P. Victorian Drug Trends 2000: Findings from the Melbourne arm of the Illicit Drug Reporting System (IDRS). NDARC Technical Report No.108 2001, Melbourne: Turning Point Alcohol and Drug Centre & National Drug and Alcohol Research Centre, University of New South Wales.
65. Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2006, 83(2):174-180. 10.1016/j.drugalcdep.2005.11.009, 16343809.
66. Quinn B. Victorian Drug Trends 2008: Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No.22 2009, Melbourne: Burnet Institute & National Drug and Alcohol Research Centre, University of New South Wales.
67. Cottler LB, Compton WM, Ben-Abdallah A, Horne M, Claverie D. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend 1996, 41(3):209-217. 10.1016/0376-8716(96)01254-9, 8842633.
68. Hunt JR, White E. Retaining and tracking cohort study members. Epidemiol Rev 1998, 20(1):57-70. 10.1093/oxfordjournals.epirev.a017972, 9762509.